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The pathogenesis of many retinal degenerations, such as age-related macular degener-
ation (AMD), is punctuated by an ill-defined network of sterile inflammatory responses. 
The delineation of innate and adaptive immune milieu among the broad leukocyte infil-
trate, and the gene networks, which construct these responses, are poorly described 
in the eye. Using photo-oxidative damage in a rodent model of subretinal inflammation, 
we employed a novel RNA-sequencing framework to map the global gene network sig-
nature of retinal leukocytes. This revealed a previously uncharted interplay of adaptive 
immunity during subretinal inflammation, including prolonged enrichment of myeloid and 
lymphocyte migration, antigen presentation, and the alternative arm of the complement 
cascade involving Factor B. We demonstrate Factor B-deficient mice are protected 
against macrophage infiltration and subretinal inflammation. Suppressing the drivers 
of retinal leukocyte proliferation, or their capacity to elicit complement responses, may 
help preserve retinal structure and function during sterile inflammation in diseases such 
as AMD.
Keywords: retinal diseases, macular degeneration, neuroinflammation, sterile inflammation, leukocytes recruitment, 
complement system proteins, innate immunity, network analysis
INTRODUCTION
Leukocyte activation and recruitment is a key process in the progression of a variety of neurodegen-
erative diseases, including those affecting the retina [reviewed in Ref. (1)]. Microglia are resident 
macrophages of the central nervous system, derived in early development from yolk sac myeloid 
cells (2, 3). Microglia contribute to the normal physiological state of the central nervous system 
through constant surveillance of the parenchyma. They control a variety of processes including 
phagocytosis of neurons during development (4), maintenance of healthy retinal synapses (5), and 
tissue repair (6). Age-related macular degeneration (AMD) is a retinal disease whose hallmark 
is progressive loss of photoreceptors and retinal pigment epithelium (RPE), accompanied by 
inflammation and influx of leukocytes, including monocyte-derived macrophages (7). Recruited 
macrophages, as well as resident microglia contribute to the pathogenesis of the degenerating retina 
[reviewed in Ref. (8, 9)], includes AMD (10–13), retinitis pigmentosa (11, 14), retinal detachment 
(15, 16), glaucoma (17–19), and diabetic retinopathy (17, 20). The long-standing assumption, 
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derived from rodent models of brain injury, is that resident 
microglia are the primary source of inflammatory mediators in 
the brain, and that recruited leukocytes do not play a long-term 
role in tissue repair [reviewed in Ref. (21)]. However, it is also 
clear from recent transcriptome studies that microglia derived 
from different parts of the CNS have distinct molecular and 
functional attributes (22).
Chemokine signaling mediates monocyte migration in several 
CNS disorders including AMD, multiple sclerosis, Alzheimer’s 
disease, and brain ischemia and trauma [reviewed in Ref. 
(23–26)]. In the photo-oxidative damage (PD) model of focal 
retinal degeneration, we used a broad spectrum chemokine 
inhibitor and reduced subretinal macrophage accumulation and 
associated photoreceptor cell death (27), indicating the key role 
of chemokines in retinal degenerations. Studies of Ccl2 show 
that ablation of Ccl2 or the Ccr2 receptor reduces monocyte 
infiltration and retinal degeneration in experimental choroidal 
neovascularization (28) and in PD-treated Cx3cr1−/− mice (29). 
Further, we have shown that expression of Ccl2 is upregulated 
in Müller cells in PD (30), and that targeted knockdown of Ccl2 
using siRNA reduces recruitment of microglia/macrophages, 
photoreceptor death, and complement deposition (31). The 
release of endogenous triggers like Ccl2 alerts monocytes and 
promotes proliferation, migration, enhanced phagocytosis, as well 
as secretion of cytokines, chemokines, and neurotoxins [reviewed 
in Ref. (32)]. This process of monocyte activation can promote 
CNS degeneration including phagocytosis of neurons that other-
wise might survive (14, 33) and initiation of pro-apoptotic events 
(34). The detrimental effects of macrophage aggregation in the 
outer retina have been directly implicated in retinal models 
of neovascular-AMD (35), PD (36, 37), diabetic retinopathy 
(38, 39), and glaucoma (40).
Despite the growing understanding of the role of macrophages 
in retinal degenerations, little is known about the molecular profile 
of these cells nor of the contribution that other leukocytes types 
may have in progression of retinal disease. While macrophages are 
the predominant inflammatory cell in the retina, a growing body 
of evidence teases a broader contribution of immune responses 
in AMD [reviewed in Ref. (41)]. Here, we report an analysis of 
gene expression in CD45+ leukocytes isolated from retina fol-
lowing experimental PD in a rodent model. Our constructed 
functional networks reveal diverse transcriptional regulation of 
genes involved in leukocyte activation, chemokine signaling, and 
the complement cascade in retinal degenerations. We propose 
that the initial inflammatory response, which primarily involves 
the retinal microglia/macrophages, leads to a progression in 
inflammatory activity, including the activation of other leukocyte 
subsets, initiation of an adaptive immune response, and comple-
ment activation, which contribute to subretinal inflammation 
and progressive photoreceptor cell death.
MATERIALS AND METHODS
Animals
All work was conducted using either young adult Sprague Dawley 
albino rats, or C57/Bl6J mice. Additionally, Cfb−/− mice (B6;129-
Cfbtm1Hrc/Apb) were also obtained from the Australian Phonemics 
Facility (APF), and which were bred on the B6 background. 
All animal experimentation was conducted in accordance with 
the ARVO Statement for the Use of Animals in Ophthalmic and 
Vision Research and with the approval of the Animal Ethics 
Committee at the Australian National University, Canberra 
(Protocols—A2012/07 and A2014/56). Both the mice colonies 
were verified by genotyping to be free of the deleterious Crbrd8 
mutation. Animals were raised and experiments were conducted 
in cyclic 5  lx light:dark (12  h:12  h), unless otherwise stated. 
All animals were culled using an overdose (60 mg/kg bodyweight) 
of barbiturate (Valabarb; Virbac, Australia) given as intraperito-
neal injection. All culling was performed at 09:00 a.m. to control 
for possible circadian effects.
PD Model
For the rat PD model, animals, housed and exposed to bright 
(1,000 lx) light for 24 h in accordance with our previous proto-
cols. Exposure began and ended at 09:00 a.m. on successive days. 
Rats were euthanized for tissue collection either immediately 
following PD (0 days), or after a further 3 or 7 days in cyclic dim 
light. Dim-reared animals were collected as non-light exposed 
controls for comparison.
The mouse PD model was performed following our previously 
established methodology (42). In brief, age-matched wild type 
(C57BL/6) and complement knockout animals were housed in 
Perspex boxes coated with a reflective interior, and exposed to 
100 K lx of natural white LED for up to 7 days, with access to 
food and water ad libitum. Each animal was administered with 
pupil dilator eye drops (0.1% atropine sulfate, Bausch and Lomb, 
Australia) two times a day during light exposure. Animals were 
either euthanized or subjected to electroretinogram (ERG) 
recordings after 3, 5, 7 days of PD.
Animal Tissue Collection and Processing 
for Histology and RNA Extraction
Eyes from some animals were marked at the superior surface for 
orientation, then enucleated and immediately immersion-fixed 
in 4% paraformaldehyde in 0.1 M PBS (pH 7.3) for 3 h at room 
temperature, then processed for cryosectioning as previously 
described for histological analysis (43). From other animals 
(n  ≥  6), retinas were excised through a corneal incision and 
prepared for cell sorting and RNA extraction.
Analysis of Cell Death
Terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL) was used to quantify photoreceptor apoptosis in 
cryosections for each experimental group, using a previously 
published protocol (44). Counts of TUNEL-positive cells in the 
outer nuclear layer (ONL) were carried out along the full length of 
retinal sections cut in the parasagittal plane (superior–inferior), 
within the vertical meridian. The total count from each retina is 
the average of four sections at comparable locations.
ONL Thickness Measurements
Thickness of the ONL in each experimental group was measured 
in increments of 1 mm along the full length of retinal cryosections 
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cut in the parasagittal plane (superior–inferior), which were in 
close proximity to the vertical meridian. The DNA-specific dye 
bisbenzimide (Sigma-Aldrich, MO, USA) was used to visualize 
the cellular layers. The ONL thickness ratio was calculated as the 
thickness of the ONL relative to the distance between the gan-
glion cell layer and ONL, to take into account any obliquely cut 
sections. The ONL thickness ratio for each retina is the average of 
two retinal sections at comparable locations.
Immunohistochemistry
To detect and localize CD45+ cells in retinal cryosections, 
immunohistochemistry was performed using a CD45 primary 
antibody (BioLegend, San Diego, CA, USA) or IBA1 (1:500, 
Wako, #019-19741), as described in our previous protocols with 
minor modifications (43, 45). Sections were counterstained with 
a DNA label (Bisbenzimide; Sigma-Aldrich) for visualization of 
the retinal layers. Fluorescence in retinal sections was visualized 
under a laser-scanning A1+ confocal microscope (Nikon, Tokyo, 
Japan), and images were acquired using the NIS-Elements AR 
software (Nikon). Images were processed using Photoshop CS6 
software (Adobe Systems, CA, USA).
Flow Cytometry for Retinal Leukocyte 
Sub-Populations
Retinal cell and dissociation and flow cytometry were conducted as 
per our previous protocol (42), with some modifications. Retinas 
from each animal were pooled and immediately placed dissocia-
tion cocktail that included 0.2% papain and were then digested 
until a single cell suspension was obtained. Permeabilization 
was not conducted. The samples were then incubated in FC 
block, followed by an incubation antibody staining buffer for 
45 min at 4°C, which contained the following cocktail of mark-
ers: CD11b-PE, 1:200, BioLegend; CD45-Alexa-647, 1:200, 
BioLegend; CD3-Pacific Blue, 1:400, BioLegend; CD45RA-FITC, 
1:200, BioLegend; Gr1-PE, 1:200, BD Biosciences, Franklin Lakes, 
NJ, USA. Samples were run through a BD Fortessa flow cytometer 
(BD Biosciences). The data were analyzed using FloJo software 
(version 10.4.1). Statistical analysis was performed using Prism 6 
(GraphPad Software, CA, USA). Unless specifically stated either 
a two-way ANOVA with Tukey’s multiple comparison posttest 
or an unpaired Student’s t-test was utilized to determine the sta-
tistical outcome, with a P value of <0.05 considered statistically 
significant.
Fluorescence-Activated Cell Sorting  
of CD45+ Leukocytes
Retinas from each animal were pooled and immediately placed in 
chilled HBSS (n = 3 per time point) and then subjected to light 
mechanical separation using a razor blade. Samples were trans-
ferred into 0.2% papain digestion cocktail (45) and incubated at 
8°C for 45 min, then 28°C for 7 min. The resulting homogenate 
was centrifuged at 250 g for 5 min at 4°C, and the pellet was resus-
pended in neutralization buffer. The homogenate was centrifuged 
again at 420 g for 5 min at 4°C, and the pellet resuspended in 
staining buffer containing 1.0% bovine serum albumin (BSA), 
and 0.1% azide. The samples were incubated in staining buffer 
containing anti-CD45-Alexa 647 (BioLegend) for 45  min at 
4°C, then washed twice in HBBS and resuspended in staining 
buffer. The resultant CD45-stained samples were run through a 
fluorescence-activated cell sorter (FACS) (BD FACSAria II; BD 
Biosciences, Franklin Lakes, NJ, USA). Viability of the sorted cells 
was assessed by labeling with DAPI. The isolated CD45+ cells 
were collected in staining buffer and kept chilled on ice until RNA 
extraction could be commenced. To prepare for RNA extraction, 
isolated samples were centrifuged at 420 g for 5 min at 4°C, and 
the supernatant removed. RNA extraction was performed with 
a combination of TRIzol Reagent (Life Technologies, Carlsbad, 
CA, USA) and an RNAqueous-small scale kit (Life Technologies, 
Carlsbad, CA, USA) utilized in tandem to extract and purify the 
RNA, respectively. Isolated total RNA was analyzed for quantity 
and purity with a ND-1000 spectrophotometer (Nanodrop 
Technologies, Wilmington, DE, USA).
RNA-Seq Sample Preparation
RNA samples were prepared for RNA-seq by the Australian 
Cancer Research Foundation (ACRF) Biomolecular Resource 
Facility (John Curtin School of Medical Research, Australian 
National University, CAN, Australia). cDNA library preparation 
was performed using the SMARTer Low RNA Kit (Clontech, 
Mountain View, CA, USA) as per the manufacturer’s instructions, 
using 679 pg of RNA per sample was used as starting material 
for the preparation of the cDNA libraries. Following library 
preparation, DNA was simultaneously fragmented and tagged 
with sequencing adaptors using an adapted Nextera DNA Sample 
preparation protocol (Illumina Technologies, San Diego, CA, 
USA—Revision A), using Ampure beads for purification (Agilent 
Technologies, Santa Clara, CA, USA). Concentrations of libraries 
were checked on the Agilent Bioanalyzer (Agilent Technologies) 
and pooled to equimolar amounts. Fragmented samples were run 
on the HiSeq2500 (Illumina Technologies), using TruSeq® Rapid 
PE Cluster Kit 2500 (Illumina Technologies) and TruSeq® Rapid 
SBS Kit 2500—200 cycles—(Illumina Technologies). 100  bp 
paired end sequencing was performed on all samples (12 sample, 
4 data points in triplicate—18.33 million reads per sample).
RNA-Seq Alignment and Analysis
All sequenced data was assessed for quality using FastQC soft-
ware (46) followed by filtering of low quality data using Trimmo-
matic software (version 0.27, LEADING:15 TRAILING:15 
SLIDINGWINDOW:4:20 MINLEN:60 trimming parameters) 
(47). All sequence data remaining as paired data after quality filter 
were mapped to the Rat genome (assembly version Rnor_5.0) 
using TopHat software (v2.0.10—b2-very-sensitive mapping 
parameter) (48) against gene annotations obtained from the 
Ensembl v75 database. Samtools (v0.1.19.0) was then used to 
remove unmapped reads and secondary alignments from TopHat 
output (fixmate-r parameters) (49). HTSeq was used for obtain-
ing tag counts for each annotated gene using default parameters 
for non-strand specific library (50). Tag counts were normalized 
for library composition and library size using trimmed mean of 
M-values method as implemented in edgeR package to obtain 
counts per million (CPM) (51, 52). Sum of tag counts in each 
sample was used as the effective library. All RNAseq data for 
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this project is available on NCBI Short Read Archive with the 
BioProject ID SRP133267.
Differential expression analysis compared the normalized 
CPM values of the light-treated groups to the control cohort 
(dim), over a time course of 0, 3, and 7 days in a pair-wise man-
ner. Genes were considered differentially expressed if they had a 
P-value of <0.05 and false discovery rate (FDR) of <0.05 (one-
way ANOVA); a fold change cut-off of 1.5 was also applied. The 
relatedness of the individual samples was assessed with principal 
component analysis (PCA) on the log2 cpm of the DEGs derived 
from each comparison, and which utilized the scatterplot3d 
package in R (v3.2.2). Venn diagrams were also created to 
illustrate overlap between data points in these gene sets (Venny, 
v2.1). Gene co-regulation across the time course was assessed by 
K-means clustering analysis on the log2 cpm of the DEGs using 
the Stats Bioconductor package in R (v2.15.0) (scripting available 
upon request). The data were further examined with heatmaps 
using hierarchical clustering via Euclidian distance, which was 
conducted with heatmapper (53).
Gene ontology (GO) term enrichment analysis was performed 
using the online bioinformatics resource Panther (v13.0) to 
identify overrepresented biological processes (BP) at each time 
point. GO analysis was conducted using statistical overrepre-
sentation, with a Bonferroni correction applied to account for 
multiple testing. Additionally, pathway analysis was performed 
using the Reactome online database (v62) to interrogate the data 
for statistically enriched pathways, as ranked by FDR (<0.05). 
To improve the interpretation of the GO terms obtained from 
Panther, an integrated network analysis was employed using 
ClueGO (v2.3.3), a plug-in for Cytoscape Software (v3.5.1) (54), 
using DEGs from each comparison. Networks were constructed 
using GO terms for biological process, and used enrichment/
depletion hyper-geometric distribution tests with an adjusted 
P-value of <0.05 (Bonferroni) for terms and groups. Kappa-
statistics score threshold was set to 0.5 to define the functional 
grouping, while the leading term for groups was selected based 
on highest significance. GO term fusion was applied to reduce the 
redundancy of the terms included in the networks.
ERG Recordings
Full-field scotopic ERG recording assessed the retinal function 
between CfB−/− and Wt mice, and used our previously published 
methodology (42). Briefly, a flash stimuli for mixed responses 
were provided by an LED-based system (FS-250A Enhanced 
Ganzfeld, Photometric Solutions International, Melbourne), 
over a stimulus intensity range of 6.3 log cd s m−2 (range −4.4 
to 1.9 log cd s m−2). The a-wave amplitude was measured from 
the baseline to the trough of the a-wave response and the b-wave 
amplitude was measured from the trough of the a-wave to the 
peak of the b-wave. Data are expressed as the mean response 
amplitude ± SEM (microvolts). Two-way ANOVA, with Tukey’s 
multiple comparisons Post hoc test, was performed to compare 
the responses over the flash stimulus range.
Western Blotting for C3d
Whole retinas from euthanized Wt or C3b−/− mice were col-
lected at 4°C in CellLytic M buffer (Sigma, Australia) containing 
protease inhibitor cocktail (Roche) and spun down at 13,000 g 
to obtain the extract protein. Concentration of samples was 
determined by Bradford assay (Bio-Rad), and equal amounts 
of total proteins were loaded onto 4–20% Mini-PROTEAN 
Tris-Glycine gels (Bio-Rad). Following electrophoresis (200 V 
for 35 min), proteins were transferred to nitrocellulose mem-
branes (Bio-Rad) in semi-dry transfer system for 30  min to 
2 h depending on the size of protein. Blots were blocked with 
3% BSA, 0.01% Tween 20, and probed overnight at 4°C with 
antibodies for either C3d (1:500, #AF2655-SP, R&D Systems) or 
the loading control GAPDH (1:4,000, #G9545, Sigma-Aldrich). 
Immunoblots were incubated with HRP-conjugated secondary 
antibodies for 2  h at room temperature and developed using 
Clarity ECL Western Blotting Substrate (Bio-Rad). Visualization 
and imaging of blots was performed on ChemiDoc MP Imaging 
System (Bio-Rad).
RESULTS
Photoreceptor Cell Apoptosis  
and Degeneration
Exposure to PD led to an increase in TUNEL-positive cells in the 
ONL (Figure 1A), and a subsequent decrease in ONL thickness 
(Figure  1B) compared to dim-reared controls. At 7  days post-
exposure, persistent ONL thinning and photoreceptor cell death 
was observed, consistent with photoreceptor death, as described 
previously (45). Photoreceptor cell death was correlated with both 
increased numbers and altered distribution of CD45+ leukocytes 
in the retina (Figure  2). CD45+ cells in retinas of dim-reared 
control animals showed localization of ramified leukocytes 
predominantly in the inner retina, with some cells present in the 
choriocapillaris (Figure S1 in Supplementary Material). At 7 days 
post-PD, CD45+ cells had an activated/rounded in morphology 
and were distributed throughout all layers of the retina including 
the ONL and the subretinal space (Figure  2A). Quantification 
of total retinal leukocytes by flow cytometry showed increased 
numbers of CD45+ cells following PD, with highest numbers 
detected at 7 days (Figure 2B). In dim-reared control animals, 
the percentage of CD45+ cells in the total retinal population 
was 0.85% compared with 6.2% 7 days post-damage (P < 0.05, 
ANOVA).
Temporal Profiling of Retinal CD45+ 
Leukocytes and Subpopulations
Common lineage markers for macrophages (CD11b), granulocytes 
(Gr1), T cells (CD3), and B cells (CD45RA) were used to investi-
gate the major subsets of CD45+ leukocytes in the retina over the 
damage time course (Figures 2C–E). The CD11b+ macrophages 
were found to increase relative to the retinal population over the 
experimental time course. This peaked at 7 days post-exposure 
(P  <  0.05, ANOVA) and detected on 5.1% of the retinal cell 
population (Figure 2C). In control samples, 57% of CD45+ cells 
positive for CD11b, while at 7 days, 85% of the CD45+ cells were 
also CD11b+, indicating that changes in the CD45+ population 
broadly reflects the changes present in the CD11b+ population. 
The subset of GR1+CD11b+ granulocytes, broadly encompassing 
FIGURE 1 | Changes in photoreceptor apoptosis and degeneration following photo-oxidative damage (PD). (A) TUNEL + photoreceptors were quantified across 
retinal sections for each replicate in each group. There was immediately increase in TUNEL + photoreceptors following PD, at 0 days, which remained significantly 
elevated at 3 and 7 days post-exposure (P < 0.05). (B) ONL thickness was averaged across retinal sections and expressed as a ratio of the total retinal thickness, 
for each sample. There was a progressive decrease in ONL thickness from 0 to 7 days post-exposure (P < 0.05). Representative images are taken from the superior 
retina, approximately 500 μm from the optic nerve head. The data depict a sample size of n = 5 per group. Asterisks equates to P-value of <0.05, as determined by 
Tukey’s post hoc test. ONL, outer nuclear layer; OS, outer segments; INL, inner nuclear layer; C, choroid.
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neutrophils and eosinophils, were shown to increase from near 
zero in dim-reared controls to ~1.5% of the retinal population at 
7 days post-damage (P < 0.05 ANOVA) (Figure 2D). The subset 
of CD3+ T cells displayed progressive increase over time, and by 
7 days comprised 20% of the CD45+CD11b− population, which 
was almost quadruple the proportion in the dim-reared controls 
(P < 0.05 ANOVA) (Figure 2E). CD45RA+ B cells in contrast 
were barely dateable and showed no appreciable change across 
the PD time course (Figure 2E).
Transcriptome Profile of Isolated CD45+ 
Retinal Leukocytes
RNAseq was performed on CD45+ cells isolated from the 
retinas over 0, 3, and 7 days post-PD to construct a temporal 
transcriptional fingerprint of immune modulation. PCA was 
performed on the individual samples for all expressed genes 
(Figure S2 in Supplementary Material). The scree plot dem-
onstrated that most of the variance was observed in the first 
three principle components (Figure S2A in Supplementary 
Material). The PCA indicated a strong correlation between 
sample replicates and highlights a rapid divergence in tran-
scriptional profile between dim-reared control leukocytes, and 
those isolated at the point of initial injury at 0 days (Figure 3B). 
Though distinct, the 3- and 7-day groups appeared more 
closely clustered together than 0 days, and the 7-day grouping 
appeared the most similar to the control cluster (Figure S2B in 
Supplementary Material).
When compared to control samples, 2,193 genes were found 
to be significantly differentially expressed in the light-treated 
groups (adjusted P < 0.05, Table S1 in Supplementary Material) 
with 1,818 DEGs identified at 0 days, and progressive decline to 
656 genes at 3 days, and 155 genes at 7 days. As this variance in 
number of DEGs has the potential to heavily bias downstream 
comparisons, we took the top 100 most significant DEGs for each 
time point, as illustrated in the volcano plots and PCA in Figure 
S3 in Supplementary Material to take forward for comparative 
functional enrichment analysis. These were representative of the 
trend in both Venn and PCA analyses that were drawn from entire 
DEG list (Figure S4 in Supplementary Material). Of the combined 
total of 300 DEGs, relatively few genes were identified in more 
than one time point, resulting in a final representative snapshot 
of 246 unique DEGs (Figure S2C in Supplementary Material). 
Of these, 82 (33.3%) were found exclusively at 0 days, compared 
to 58 (23.6%) and 61 (24.8%) for 3- and 7-day groups, respec-
tively. The 3- and 7-day groups were also found to share the most 
DEGs (27, 11%), as opposed to a total of only 9 (3.7%) with the 
0 days group. These patterns indicate the greatest transcriptional 
changes in retinal leukocytes occurring within the first 24 h, and 
most of these are acutely resolved within a week after injury.
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FIGURE 2 | Continued
FIGURE 2 | Characterization of major CD45 leukocyte subsets in the retina following photo-oxidative damage. (A) Representative labeling of CD45+ cells (green) by 
immunohistochemistry on retinal sections, with DAPI (blue) as the background stain. At 7 days post damage, there were numerous CD45+ cells distributed in the 
ONL and subretinal space following damage (B,D). (B) Graphing and representative plots for florescence activated cell sorting (FACS) of CD45+ cells, which show 
progressive increases over time, relative to the retinal population (P < 0.05, ANOVA). (C–E) Categorization of CD45 subpopulations in the retina over the timecourse, 
using flow cytometry. (C) The proportion of CD11b+ macrophages comprised the bulk of the CD45+ population (F, left, P < 0.05, ANOVA), and continually 
increased throughout the timecourse relative to the retinal population (F, right, P < 0.05, ANOVA). (D) Graphing and representative plots showcase CD11b and Gr1 
staining among CD45 cells, relative to the retinal population. CD11b+Gr1+ granulocytes were found exhibit late increase at 3 and 7 days (ANOVA P < 0.05), 
comprising a smaller proportion than the CD11b+Gr1− macrophage subset. The representative SSC/FSC plots at 3 and 7 days show increased SSC of 
CD11b+Gr1+ granulocytes compared to CD11b+Gr1−. (E) Staining for CD3+ T cells and C45RA+ B cells is presented in graphs and representative plots as a 
proportion of the CD45+CD11b− parent population. The subset of CD3+ cells displayed progressive increase over time, and peaking at 7 days (P < 0.05 ANOVA); 
CD45RA+ cells in contrast showed no appreciable change across the timecourse. All datasets represent a sample size of n = 4 per group. C, choroid; FACS, 
fluorescence-activated cell sorting; INL, inner nuclear layer; ONL, outer nuclear layer; OS, outer segments.
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Network Analysis of CD45+ Leukocyte 
Transcriptome
To gain insight into the BP, which mark the temporal shift in 
the CD45+ transcriptome over the course of pathology, GO 
analysis was performed on the list of Top 100 DEGs at each point 
(Table S2 in Supplementary Material). Lists of GO:BP terms to 
showcase the Top 10 terms ranked by significance for each point 
(Table 1, adj. P < 0.05). A striking observation from this analysis, 
however, was the extent to which these enriched BP were being 
driven by small clusters of genes (Table 1, network genes). This 
was particularly evident at the 0-day point, wherein a subset of 
chemokines (Ccl2, Cxcl16, Cxcl11, Ccl12, Ccl7, Ccl22, and Ccl17) 
was shown to underscore almost all the biology illustrated by the 
top ranked terms.
To facilitate a better understanding of the biological signifi-
cance of the data, we used ClueGO to integrate enriched GO:BP 
terms from each point and organize them into a combined func-
tional network (Figure 3). This enabled us to explore functional 
interrelationships across a broad biological network, while also 
understanding redundancy of terms between related functions. 
Figure  3A represents the global functional network of retinal 
CD45+ population using GO:BP terms constructed from the 
combined Top 100 DEGs from each time point, and showcase 
functional grouped clusters such as lymphocyte migration, 
positive regulation of hemopoiesis, and nuclear division. In 
Figure  3B, enrichment of specific points across the network 
is displayed as proportion (%) of associated genes (complete 
readout of GO terms and gene are tabulated in Table S3 in 
Supplementary Material). Here, the data reveal a shift in enrich-
ment over the course of PD. The 0 days point was most repre-
sented in the lymphocyte migration functional group (69.2%), as 
well as networked terms for monocyte and neutrophil migration 
(61.4, 66.7%), extravasation (100%) interleukin 1 (80%), con-
versely, there was pronounced enrichment of functional groups 
that underscore cellular proliferation and metabolism, including 
nuclear division (89.4%) and glycolytic process (68.3%). After 
7 days, there was a shift toward adaptive immune response, with 
pronounced representation of terms relating to antigen process-
ing and presentation (74%), including MHC class I (100%), and 
T  cell receptor (TCR) signaling pathway (77.4%). Individual 
functional networks were also constructed for the individual 
time points (Figure S5 in Supplementary Material), though 
were found to explain the data in a largely similar fashion to the 
combined network.
Gene Co-Regulation Using K-Means 
Clustering
The co-regulation of DEGs over the damage time course was 
assessing using K-means clustering, which was performed on the 
combined list of 246 unique DEGs. The analysis identified four 
major clusters as shown in heat maps and graphs in Figure  4; 
more detailed heat-maps showing the specific genes in each 
cluster are located in Figure S6 in Supplementary Material. Based 
on their temporal expression profile, the clusters were variously 
classed as Early Up (A), Mid Up (B), Late Up (C), and Global 
Down (D), and GO:BP and reactome pathway analysis were 
performed on each to identify significantly enriched terms and 
pathways. The top 10 entries for each analysis (ranked by adj. 
P value) are listed in Figures 4A–D (the complete list is available 
in Table S4 in Supplementary Material).
The Early Up cluster (Figure 4A) identified DEGs that exhib-
ited peak upregulation at 0  days, and mainly comprised GO 
terms associated with recruitment, including leukocyte migration 
(GO:0050900), monocyte chemotaxis (GO:0002548), and gra-
nulocyte chemotaxis (GO:0071621). These consisted of many 
overlapping chemokines such as Ccl2, Ccl3, Ccl7, Ccl12, as well as 
the pro-inflammatory regulators Anxa1 (Annexin A1) and Spp1 
(Osteopontin), and the immune suppressor lgals1 (Galectin-1). 
Pathway analysis, conversely, identified many apoptosis-related 
entries such as caspase-mediated cleavage of cytoskeletal proteins 
(R-RNO-264870) and apoptotic execution phase (R-RNO-75153). 
These enriched chemokine pathways are representative of the entire 
DEG list at the 0  days timepoint (Figure S7 in Supplementary 
Material).
Mid Up (Figure  4B) correlated with peak upregulation at 
3 days. Both GO terms and pathways associated with this time 
point were dominated by proliferative responses, including 
mitotic cell cycle (GO:0000278) and Mitotic Spindle Checkpoint 
(R-RNO-69618). Also enriched, however, was lymphocyte 
chemotaxis (GO:0048247), consisting of the Adam8 and the 
chemokines Cxcl9, Cxcl11, Ccl22, and Ccl17. Other chemokines 
in this cluster also include the Xcl1-Xcr1 signaling axis (Figure 
S6A in Supplementary Material). Late up (Figure 4C) clustered 
DEGs that exhibited peak upregulation and 7 days and revealed 
terms for antigen processing and presentation of peptide antigen 
(GO:0048002), and pathways associated with T-cell activation, 
including translocation of ZAP-70 to immunological synapse 
(R-RNO-202430), phosphorylation of CD3 and T cell receptor 
(TCR) zeta chains (R-RNO-202427). Strikingly, the complement 
FIGURE 3 | Functionally grouped network analysis of enriched GO terms for CD45 Population over the timecourse. (A) The top 100 DEGs from each timepoint were 
used to generate enriched GO terms for biological process, which were then integrated into a functionally grouped network. GO:BP terms are represented as 
nodes, while their size illustrates the significance of the term enrichment; the edges reflect the degree of connectivity and grouping between the terms. The leading 
term in each functional grouping is selected based on the highest significance (Bonferroni adj. P < 0.05). (B) The network is overlayed with the enrichment of the 
timepoints across the functional groupings; nodes in which more than 50% of the genes are attributed to a given timepoint are color-coded accordingly. BP, 
biological process; DEG, differentially expressed gene; GO, gene ontology.
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TABLE 1 | Functional overrepresentation of gene ontology (GO):BP terms in panther.
GO biological process complete Background 
set
Network 
set
Network fold 
enrichment
Adjusted 
P-value
Network genes
Control vs 0 days
Lymphocyte chemotaxis (GO:0048247) 34 8 69.26 5.14E−09 Adam8, Ccl2, Cxcl16, Cxcl11, Ccl12, Ccl7, Ccl22, Ccl17
T cell migration (GO:0072678) 19 4 61.97 6.73E−03 Ccl2, Cxcl16, Cxcl11, Itgb7
Lymphocyte migration (GO:0072676) 45 9 58.87 7.12E−10 Adam8, Ccl2, Cxcl16, Cxcl11, Ccl12, Ccl7, Itgb7, Ccl22, 
Ccl17
Monocyte chemotaxis (GO:0002548) 30 6 58.87 1.24E−05 Anxa1, Ccl2, Ccl12, Ccl7, Ccl22, Ccl17
Mononuclear cell migration (GO:0071674) 33 6 53.52 2.18E−05 Anxa1, Ccl2, Ccl12, Ccl7, Ccl22, Ccl17
Granulocyte chemotaxis (GO:0071621) 65 7 31.7 3.38E−05 Anxa1, Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17
Neutrophil chemotaxis (GO:0030593) 58 6 30.45 6.00E−04 Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17
Granulocyte migration (GO:0097530) 71 7 29.02 6.17E−05 Anxa1, Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17
Chemokine-mediated signaling  
pathway (GO:0070098)
61 6 28.95 8.05E−04 Ccl2, Cxcl11, Ccl12, Ccl7, Ccl22, Ccl17
Neutrophil migration (GO:1990266) 63 6 28.03 9.72E−04 Ccl2, Spp1, Ccl12, Ccl7, Ccl22, Ccl17
Control vs 3 days
Regulation of chromosome segregation 
(GO:0051983)
86 6 19.99 6.93E−03 Ube2c, Dusp1, Pttg1, Knstrn, Bub1b, Spag
Mitotic sister chromatid segregation 
(GO:0000070)
95 6 18.1 1.23E−02 Aurk, Pttg1, Knstrn, Kiff22, Cxc20, Spag5
Mitotic nuclear division (GO:0140014) 131 8 17.5 2.38E−04 Ube2c, Aurkb, Pttg1, Knstrn, Tpx2, Kiff22, Cdc20, Spag5
Sister chromatid segregation (GO:0000819) 119 7 16.86 2.42E−03 Ube2c, Pttg1, Knstrn, Bub1b, Kif22, Cdc20, Spag5
Spindle organization (GO:0007051) 122 7 16.44 2.86E−03 Ube2c, Cep72, Knstrn, Stmn1, Tpx2, Cdc20, Spag5
Nuclear division (GO:0000280) 263 11 11.99 2.35E−05 Ube2c, Aurkb, Rad51, Pttg1, Knstrn, Bub1b, Tpx2, Kiff22, 
Cdc20, Spag5
Regulation of nuclear division (GO:0051783) 170 7 11.8 2.55E−02 Ube2c, Tnf, Dusp1, Pttg1, Bub1b, Cdc20, Ifg1
Mitotic cell cycle process (GO:1903047) 395 16 11.61 5.61E−09 Ube2c, Aurkb, Iqgap3, Rad51, Kif20a, Pttg1, Knstrn, Bub1b, 
Stmn1, Cdkn3, Tpx2, Kiff22, Ier3, Cdc20, Spag5
Mitotic cell cycle (GO:0000278) 457 18 11.29 2.58E−10 Ube2c, Aurkb, Iqgap3, Nuf1, Rad51, Kif20a, Pttg1, Cenpw, 
Knstrn, Bub1b, Stmn1, Cdkn3, Tpx2, Kiff22, Ier3, Cdc20, 
Spag5
Organelle fission (GO:0048285) 294 11 10.72 7.35E−05 Ube2c, Aurkb, Rad51, Pttg1, Knstrn, Bub1b, Tpx2, Kif22, 
Cdc20, Spag5
Control vs 7 days
Antigen processing and presentation 
of peptide antigen via MHC class I 
(GO:0002474)
29 4 46.22 2.11E−02 RT1-T24-4, RT1-CE10, RT1-CE5, RT1-CE5
Antigen processing and presentation of 
peptide antigen (GO:0048002)
47 6 42.78 7.93E−05 RT1-T24-4, RT1-CE10, RT1-CE5, Cd74, RT1-CE5, RT1-Da
Antigen processing and presentation 
(GO:0019882)
79 6 25.45 1.66E−03 RT1-T24-4, RT1-CE10, RT1-CE5, Cd74, RT1-CE5, RT1-Da
Cell adhesion (GO:0007155) 654 11 5.64 3.79E−02 Itgae, Tnf, Gpnmb, Axl, Rom1, Cd63, Mfge8, Cldn1, Lgals3bp, 
Cdh17, Cd96
Biological adhesion (GO:0022610) 663 11 5.56 4.32E−02 Itgae, Tnf, Gpnmb, Axl, Rom1, Cd63, Mfge8, Cldn1, Lgals3bp, 
Cdh17, Cd96
Immune response (GO:0006955) 798 13 5.46 6.23E−03 Fut7, Tnf, RT1-T24-4, Cfb, Cxcl13, Cldn1, RT1-CE5, Cd74, 
Cdh17, RT1-CE5, Skap1, RT1-Da
Cell surface receptor signaling pathway 
(GO:0007166)
1,591 18 3.79 6.48E−03 Itgae, Tnf, Card14, Axl, Csf2ra, Sulf1, Evc, Rom1, Cd63, 
Adgre5, Cxcl13, PLxnc1, Cxcr6, Cxcr3, Cd74, Cdh17, Cd3e, 
Skap1
Immune system process (GO:0002376) 1,607 18 3.75 7.50E−03 Ctnnbl1, Fut7, Tnf, Axl, RT1-T24-4, Cfb, Ifitm1, Cxcl13, Cldn1. 
RT1-CE10. Cxcr3, RT1-CE5, Cd74, Cdh17, RT1-CE5 Cd3e, 
Skap1, RT1-Da
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activator Factor B (cfb) was also present in the Late-up cluster, 
alongside an enrichment of pathways associated with Alternative 
complement activation (R-RNO-173736) and Activation of C3 
and C5 (R-RNO-174577); these are further illustrated in path-
way diagrams depicted in Figure 5. The Global-DOWN Cluster 
(Figure  4D), unlike the other groupings, did not return any 
significantly enrich terms for GO:BP.
Effect of Factor B Ablation on Subretinal 
Inflammation Following PD
The pronounced enrichment of alternative complement pathway 
and Factor B within the K-means data led us to further explore 
its role in subretinal inflammation and photoreceptor degen-
eration after PD. Interrogation of the full list of 2,193 DEGs 
revealed further significant differences in the complement genes, 
FIGURE 4 | Analysis of co-regulated DEGs within the CD45 population following photo-oxidative damage. (A–D) K-means clustering was performed on the 
log2 cpm of 246 DEGs that were derived from the combined top 100 DEGs in each timepoint. Four major clusters were identified, as illustrated in the heat maps 
and box and whiskers plots, and variously termed (A) Early Up, (B) Mid Up, (C) Late Up, and (D) Global Down, based on their temporal expression pattern. The 
DEGs in each cluster were assessed for enriched terms and pathways using GO:BP and Reactome, respectively; the top entries for each are displayed, which were 
ranked according to the adjusted P value. Abbreviations: BP, biological process; DEG, differentially expressed gene; GO, gene ontology.
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including alternative Factor D (Cfd), and classical components 
C1qa, C1qb, and C1qc (Figure  6C). Hierarchical clustering on 
the genes revealed an early decrease (0 days) in the cluster of C1q 
components, while both the alternative pathway Factors B and 
D showed increased expression at 7 days, in agreement with the 
K-means pathway analysis.
FIGURE 5 | Enrichment of the complement pathway in the CD45 transcriptome. (A,B) Reactome pathway diagrams showcase overrepresentation [false discovery 
rate (FDR) <0.05] of complement interactions in the Late UP K-means Cluster. Yellow-coloring in the nodes denotes a gene in the expression list that matches a 
protein within the pathway diagram, while the degree of coloring represents the coverage. (A) Pathway diagram depicts the entire complement cascade, which are 
broadly classified subcomponents for initial triggering of complement (blue), terminal pathway of complement (green), activation of C3 and C5 (red), and regulation of 
the complement cascade (gray). (B) Activation of C3 and C5 was found to show significant enrichment Factor B (cfb) in the expression list (yellow-coloring). (C) Heat 
maps with hierarchical clustering on significant complement DEGs derived from the full gene expression list (2,193). Asterisks denote significant differential 
expression (FDR < 0.05) compared to control (dim). Abbreviation: DEG, differentially expressed gene.
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To investigate a possible functional role, we utilized a Cfb−/− 
knockout strain and a murine PD model that we had previously 
shown exhibits a similar magnitude of photoreceptor death and 
sterile inflammation to the rat model, over a 7-day time course of 
bright-light exposure (42). We examined the expression of Factor 
B in whole mouse retinas after 3, 5, or 7 days’ PD, and observed 
its persistent upregulation compared to dim-reared retinas 
(Figure 6A; P < 0.05). This correlated with increased number of 
TUNEL +  photoreceptors, following PD over the same period 
(Figure 6A; P < 0.05).
The link between photoreceptor viability and complement 
factor B was further examined in Wt and Cfb−/− mice using 
TUNEL, ONL thickness, and ERG recordings (Figures 6B–H). 
After 7 days’ exposure to PD, fewer TUNEL + photoreceptors 
and more surviving photoreceptor rows were observed in 
Cfb−/− mice, compared to Wt (Figures  6B–D; P  <  0.05). In 
conjunction, ERG analysis indicated significantly better retinal 
function in the Cfb−/− cohort, which had higher mixed a- and 
b-wave flash responses than the Wt group (Figures  6E–H; 
P < 0.05). The status of complement within retinas of CfB−/− 
and Wt was inferred by Western blotting for C3d (Figure 6I), 
a relatively long-lived by-product of C3 proteolysis whose 
accumulation infers activation of the cascade (55). After 7 days 
PD, there were significantly lower levels of C3d in retinas of 
CfB−/− mice, compared to Wt (P < 0.05), accompanied by fewer 
infiltrating IBA1-immunoreactive macrophages in the ONL/
subretinal space (P < 0.05, Figure 6J). IBA1 + macrophages in 
the Wt cohort more frequently exhibited a reactive amoeboid-
type morphology (Figure 6J, representative images), indicative 
of an activated state.
DISCUSSION
In this study, we provide the first detailed characterization of 
the functional dynamic of the retinal leukocyte population in 
sterile retinal inflammation, combining flow-cytometry analysis 
with RNA-seq of retinal CD45+ transcriptome. Whole-genome 
transcriptional profiling has been used previously to facilitate 
high-resolution analysis of the host gene response to cellular 
changes in the retina (56–58), though these studies have lacked 
the necessary resolution to dissect the leukocyte populations 
driving tissue damage after sterile injury. Here, we show that the 
major leukocyte cell type and associated molecular changes are 
consistent with a mononuclear phagocyte subpopulation, most 
likely tissue-resident microglia and macrophages. PD induced an 
early pro-inflammatory and chemokine-driven response that laid 
the foundation for progressive and varied migration of myeloid 
cells, granulocytes, and T lymphocytes at later stages, which was 
coincident with photoreceptor cell loss. In assessing the gene 
expression changes using a functional network approach, we 
uncovered shifts in the retinal leukocyte transcriptome following 
sterile injury, predicting that the major drivers of the degenera-
tive process are mediated by a sustained inflammatory response. 
Specifically, early myeloid-driven, acute pro-inflammatory 
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FIGURE 6 | Continued
responses preceded any later involvement of complement, T-cell 
activation, antigen presentation.
Network analysis predicted a role for alternative comple-
ment pathway during the late stage of degeneration and 
indicated that this was driven by leukocytes at 3–7 days post 
injury. Factor B is crucial to the assembly of the alternative 
pathway C3-convertase, which promotes the rapid and prodi-
gious accumulation of C3b/C3d, and ultimately, the assembly 
FIGURE 6 | Effect of Cfb ablation on retinal degeneration complement activation, and macrophage infiltration following PD. (A) Temporal relation of retinal cfb 
expression and TUNEL + photoreceptor counts PD was assessed in Wt mice after 3, 5, and 7 days PD. The expression of Cfb showed continual upregulation 
following PD, compared to dim-reared (P < 0.05) and was in concert with increase in TUNEL + photoreceptors (P < 0.05). Representative florescent images 
showcase TUNEL staining (red) over the timecourse of PD. (B–D) Change in TUNEL-photoreceptor counts and ONL thickness in Wt vs Cfb−/− mice, after 7 days 
PD. TUNEL+ across the full length of retinal sections were quantified and found to be reduced in Cfb−/− mice [(B), P < 0.05]; these are depicted in representative 
images. ONL thickness was extrapolated on the same sections as function of the number of photoreceptor rows (C,D). When quantified over sections (C), there 
were more surviving photoreceptors in Cfb−/− mice, compared to Wt (P < 0.05), and was particularly pronounced in mid-periphery [~1 to 1.5 mm eccentricity (D)]. 
(E–H) ERGs recordings capture a flash intensity series (−4.4 to 1.9 cd.s/ms2) conducted on Wt and Cfb−/− cohorts after 7 days PD. The trend for both analyzed 
b- and b-waves across this series was higher Cfb mice than Wt (E,F), in addition to highest flash intensity [(G), P < 0.05]. The cone-derived b wave was analyzed at 
from a twin-flash stimulus at 1.9 cd.s/ms2 and was also significantly higher in the Cfb−/− cohort [(H), P < 0.05]. (I) Representative immunoblots illustrate bands for 
complement C3d protein and loading control GAPDH in whole retinas, from CfB−/− and WT cohorts after 7 days PD. Densitometry quantified C3d levels, 
normalized to GAPDH, and indicated reduced C3d levels in the Cfb−/− cohort (P < 0.05). (J) Immunohistochemistry for IBA1 + macrophages/microglia (green) in 
retinal sections of Wt vs Cfb−/− mice after 7 days PD, as shown in representative images. The graph illustrates the quantification of IBA1+ cells in the ONL and 
subretinal space across retinal sections and show a significant decrease in the Cfb−/− cohort, compared to Wt (P < 0.05). Statistical significance was determined 
by Student’s t-test or ANOVA accompanied with post hoc multiple comparison (*P < 0.05). (A–H): N = 5 per group; (I–J): N = 4 and 11 per group. Abbreviations: 
ERG, electroretinogram; INL: inner nuclear layer; ONL: outer nuclear layer; PD, photo-oxidative damage. Scale bars equal to 50 μm.
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of the membrane attack complex, which in turn may trigger 
cytolysis or apoptosis of target cells (59, 60). Factor B expres-
sion is increased in retinal macrophages/microglia in aged mice 
(61), though the implications of this expression, particularly 
in the context of sterile inflammation, has not previously been 
assessed. Here, we present several lines of evidence indicating 
that increased expression of Factor B promotes local activation 
of the alternative complement pathway, including deposition 
of complement C3, and that this is mediated by subretinal 
macrophage infiltration.
Age-related macular degeneration is considered a chronic 
inflammatory disease exacerbated by dysfunction and dysregula-
tion of the complement cascade [reviewed in Ref. (62, 63)]. Much 
attention has been placed on the regulation of Complement Factor 
H (Cfh), and thus the alternative pathway [reviewed in Ref. (64)], 
due to the strong genetic link between Cfh dysregulation and 
AMD pathogenesis (65–68). The alternative pathway has been 
implicated in complement activation and retinal pathology in 
several animal models [reviewed in Ref. (69)]. This relates favora-
bly to our previous observations, showing that C3 is expressed by 
infiltrating mononuclear phagocytes following PD, and that this 
expression is integral to the pathogenic activation of complement 
within the retina (70).
It is well known that the major leukocytes in the central nerv-
ous system are microglia, the resident macrophages [reviewed 
in Ref. (71)]. Previous studies have used CD11b+ as a leukocyte 
marker for isolating retinal macrophage populations (72) and 
have shown that this population accounts for 5–20% of the glial 
population (73). Despite CNS microglia being classed as CD45lo 
expressed (74, 75), in the current study, we found that CD45 
labeling produced a similar profile to CD11b, but comprise a 
broader pool of cells, therefore, providing a better perspective on 
the leukocyte expressome. Our data show that while in control 
animals (reared in dim light) CD11b+ cells are ~0.495% (±0.09 
SEM) of the retinal population, CD45+ cells comprise ~0.853% 
(±0.23 SEM). However, at 7  days after light damage, CD11b+ 
cells were 5.07% (±0.530 SEM) while CD45+ cells 6.21% (±0.730 
SEM) of the retinal cell population, respectively. These data 
indicate that the molecular profile of the CD45+ cell population 
changes with retinal degeneration. Moreover, the early expres-
sion of chemokines suggests that the increase in the proportion 
of CD45+ cells is due to a recruitment of monocytes as well as a 
change in the local retinal environment.
Previous studies have demonstrated that recruited mac-
rophages do not contribute to the microglial pool under normal 
physiological conditions (76). However, recent evidence from 
Ma and colleagues in an NaIO3-induced model of RPE loss 
indicates that recruited macrophages may aid in replenishing the 
microglial pool of the inner retinal during injury. In that study, 
recruited macrophages were found to seed the inner retina in a 
Ccr2-dependant fashion following RPE degeneration and adopt a 
long-lived phenotype synonymous with resident microglial cells 
(77). Our gene expression data support this finding in showing 
that microglia-associated markers transmembrane protein 119 
(Tmem119), P2Y purinoceptor 12 (P2ry12), and Sal-like protein 
1 (Sall1) are all transiently downregulated in the CD45+ popula-
tion, at 0 days (Table S1 in Supplementary Material), suggestive 
of a dilution of the microglial pool with the rapid recruitment of 
non-resident mononuclear phagocytes. Despite these collective 
findings, the dissection of the respective functional roles of resi-
dent vs recruited macrophage populations in the retina remains 
elusive. Fate mapping strategies, such as that reported recently by 
O’Koren and colleagues (75) may further assist in contrasting the 
roles these populations in future studies.
Network analysis of leukocyte gene expression also highlighted 
waves of chemokine-mediated cell recruitment. Chemokines 
play a pivotal role in leukocyte migration and activation (78) and 
are implicated in experimental models of retinal degeneration 
(45, 79) and in AMD disease progression (29, 80). These small 
molecules are grouped according to the relative position of their 
first N terminal cysteine residues, into C (γ chemokines), CC 
(β chemokines), CXC (α chemokines), and CX3C (δ chemokines) 
(23, 81, 82). Many of the receptors show a degree of redundancy, 
although generally interactions are restricted to within chemokine 
family subclasses (23). We find significant changes in expression 
of a number of chemokines by CD45+ cells in retinal degenera-
tion, covering the gamut of myeloid and T lymphocyte chemo-
taxis. The significant increases in Ccl2, Ccl3, and Ccl7 at 0 days 
corroborate findings from our previous studies of whole retinas 
(30, 45). Here, we show in addition that Ccl12, Ccl17, Ccl22, as 
well as Cxcl4, Cxcl10, Cxcl11, Cxcl13, Cxcl16 are expressed by 
leukocyte subsets in the retina at early stage of degeneration. The 
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chemokine expression profile at 3–7  days also indicated some 
striking novel patterns, including strong upregulation of Cxcl9, 
Xcl1, and Xcr1 axis. In a previous study, a downregulation of 
Cxcl9 was observed in IFN-β-treated RPE cells, and suggested 
to be an immune-suppressive mechanism that protects the retina 
from excessive inflammation (83). The ligand Xcl1 is expressed 
primarily by activated CD8+ T cells in peripheral blood, while 
its cognate receptor Xcr1 is present mainly on dendritic cells 
[reviewed in Ref. (84)]. This signaling axis augments T cell sur-
vival and promotes cytotoxic immune responses (85, 86).
Our network analysis showed that CD45+ expression profile 
at the later stage of sterile inflammation heavily skewed toward 
antigen-presentation and processing via MHCI and MHCII, 
as well as activation and signaling through the T  cell receptor. 
In human forms of sterile retinal inflammation, such as AMD, 
the evidence linking disease progression to the adaptive immune 
system has been poorly investigated, even though the presence 
of anti-retinal antibodies in AMD patients has been reported 
(87–89). Others have suggested that AMD should be considered 
an autoimmune disease [reviewed in Ref. (90)], noting that evalu-
ations of AMD lesions demonstrate the presence of both mast 
cells and lymphocytes (91). Because the retina is not routinely 
surveyed by B- and T-cells under physiological conditions, any 
involvement of the adaptive immune system to retinal degen-
erations will most likely involve retinal antigen presentation 
and indirect autoantibody function (41). T-cells and neutrophil 
participation in RPE degenerations has also been reported 
(92, 93), while others have implicated the complement system 
as the bridge between the adaptive and innate immune system 
(94, 95), leading to the recruitment of γδ T-cells (96). A study 
that induced AMD-like retinal degeneration through the use of 
carboxyethylpyrrole-modified albumin (CEP) (97) suggests that 
an antibody-mediated response to CEP is required to initiate 
degeneration and implicates T-cells and B-cells. Further, this 
CEP-immunized AMD-like model demonstrates macrophage 
recruitment to the site of injury and complement activation in 
the Bruch’s membrane, also suggesting activation of the classi-
cal pathway (97). The study also shows that CEP-immunized 
Rag−/− mice, which lack intact adaptive immunity and mature 
T-cells and B-cells, produced no anti-CEP.
CONCLUSION
Sterile inflammation punctuates the degenerative process of 
many ocular pathologies, though despite this, the breadth and 
scope of this response in the context of the retinal environment 
are poorly characterized. Though mononuclear phagocytes 
comprise the bulk leukocyte infiltrate, profiling the CD45+ 
subset did reveal an early and pronounced enrichment of terms 
pertaining to T-cell chemotaxis and migration, while prolifera-
tion, T-cell activation, antigen presentation, and complement 
dominated ontologies at the later time points. Finally, our 
mechanistic data strongly support a key role of leukocytes, 
and in particular, mononuclear phagocytes, in propagating 
the subretinal inflammation and complement deposition via 
the activation of the alternative pathway. Together, these data 
greatly extend our understanding of the factors that shape the 
course of sterile retinal inflammation, which has relevance 
to the therapeutic targeting of these pathways in diseases 
such AMD.
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